Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activating transcription factor 4 pseudogene 2 (ATF4P2) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a normal gene but nonfunctional; it does not produce a protein product. ATF4P2 is related to the protein-coding gene ATF4, which plays important roles in cellular stress responses as a transcription factor, but ATF4P2 itself has no known biological function or role as a therapeutic target[5]. There is no evidence that ATF4P2 acts as a receptor, enzyme, transporter, or transcription factor[5]. If you are interested in the functional, protein-coding ATF4 gene, please specify, as the information above applies strictly to the pseudogene ATF4P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activating transcription factor 4 pseudogene 2 (ATF4P2).